The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
(Yicai) Dec. 31 -- Shares of Everest Medicines dropped after the Chinese biopharmaceutical company's immunoglobulin A ...
Health policy is not always a straightforward topic of discussion. There are many aspects to the complex health care system ...
Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...
Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
Making medical policy based on racial stereotypes harmed all Black Americans waiting for a kidney. This lawsuit is brought by ...
In the past decade, we have seen tremendous advances in the prevention, treatment and management of chronic kidney disease ...
UCSF doctors have developed a system for weaning people off a protocol that could have profound benefits for otherwise ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
The FDA rejected the company's drug in June due to a problem with a contract manufacturer.
East Idaho News on MSN
Kidney stones explained: causes, symptoms and how to prevent them
Q: What are kidney stones, and how do I prevent them? Kidney stones are common, impacting approximately one in five men and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback